Women with breast cancer who are receiving dose-dense paclitaxel are more likely to experience paclitaxel-induced peripheral neuropathy (PIPN) when compared with women who receive the treatment weekly,...
As neurocognitive decline occurs in the majority of patients with breast cancer, researchers conducted a blind randomized trial to determine if aerobic exercise was an effective intervention for reducing...
Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...
The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
Researchers performed a retrospective, single-center, observational cohort study to evaluate the safety outcomes of standard vs rapid infusion rates in patients who received oxaliplatin.
Researchers determined the impact of melanoma subtypes on cutaneous immune-related adverse events and survival among those who received immune checkpoint inhibitor therapy.
The American Heart Association (AHA) addresses the adverse effect of hypertension in patients receiving anticancer therapies and how the disease should be managed.
The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
